<!DOCTYPE html>
<html lang="en"><head>
<script src="non-atherosclerotic-vascular-diseases-_files/libs/clipboard/clipboard.min.js"></script>
<script src="non-atherosclerotic-vascular-diseases-_files/libs/quarto-html/tabby.min.js"></script>
<script src="non-atherosclerotic-vascular-diseases-_files/libs/quarto-html/popper.min.js"></script>
<script src="non-atherosclerotic-vascular-diseases-_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="non-atherosclerotic-vascular-diseases-_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="non-atherosclerotic-vascular-diseases-_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="non-atherosclerotic-vascular-diseases-_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="non-atherosclerotic-vascular-diseases-_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.3.340">

  <title>non-atherosclerotic-vascular-diseases-</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/dist/theme/quarto.css" id="theme">
  <link href="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    margin-bottom: 0.5rem;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAYAAABzenr0AAAAAXNSR0IArs4c6QAAAERlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA6ABAAMAAAABAAEAAKACAAQAAAABAAAAIKADAAQAAAABAAAAIAAAAACshmLzAAACV0lEQVRYCdVWzWoUQRCuqp2ICBLJXgITZL1EfQDBW/bkzUMUD7klD+ATSHBEfAIfQO+iXsWDxJsHL96EHAwhgzlkg8nBg25XWb0zIb0zs9muYYWkoKeru+vn664fBqElyZNuyh167NXJ8Ut8McjbmEraKHkd7uAnAFku+VWdb3reSmRV8PKSLfZ0Gjn3a6Xlcq9YGb6tADjn+lUfTXtVmaZ1KwBIvFI11rRXlWlatwIAAv2asaa9mlB9wwygiDX26qaw1yYPzFXg2N1GgG0FMF8Oj+VIx7E/03lHx8UhvYyNZLN7BwSPgekXXLribw7w5/c8EF+DBK5idvDVYtEEwMeYefjjLAdEyQ3M9nfOkgnPTEkYU+sxMq0BxNR6jExrAI31H1rzvLEfRIdgcv1XEdj6QTQAS2wtstEALLG1yEZ3QhH6oDX7ExBSFEkFINXH98NTrme5IOaaA7kIfiu2L8A3qhH9zRbukdCqdsA98TdElyeMe5BI8Rs2xHRIsoTSSVFfCFCWGPn9XHb4cdobRIWABNf0add9jakDjQJpJ1bTXOJXnnRXHRf+dNL1ZV1MBRCXhMbaHqGI1JkKIL7+i8uffuP6wVQAzO7+qVEbF6NbS0LJureYcWXUUhH66nLR5rYmva+2tjRFtojkM2aD76HEGAD3tPtKM309FJg5j/K682ywcWJ3PASCcycH/22u+Bh7Aa0ehM2Fu4z0SAE81HF9RkB21c5bEn4Dzw+/qNOyXr3DCTQDMBOdhi4nAgiFDGCinIa2owCEChUwD8qzd03PG+qdW/4fDzjUMcE1ZpIAAAAASUVORK5CYII=');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">


<section class="slide level2">


<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B10.jpg" class="r-stretch"></section>
<section id="pathology-of-vessels-non-atherosclerotic-vascular-diseases" class="title-slide slide level1 center">
<h1>Pathology of VesselsNon-Atherosclerotic Vascular Diseases</h1>

</section>

<section id="serdar-balci-md" class="title-slide slide level1 center">
<h1>Serdar BALCI, MD</h1>

</section>

<section id="pathology-of-vessels" class="title-slide slide level1 center">
<h1>PATHOLOGY OF VESSELS</h1>

</section>

<section id="pathology-of-vessels-1" class="title-slide slide level1 center">
<h1>Pathology of Vessels</h1>
<ul>
<li><strong>Narrowing, complete obstruction of vessel lumina</strong>
<ul>
<li><strong>Progressively</strong>
<ul>
<li><strong>Atherosclerosis</strong></li>
</ul></li>
<li><strong>Acutely</strong>
<ul>
<li><strong>Thrombosis or embolism</strong></li>
</ul></li>
</ul></li>
<li><strong>Weakening of vessel walls</strong>
<ul>
<li><strong>Dilation and/or rupture</strong></li>
</ul></li>
</ul>
<p><strong>Different vascular structures for different purposes</strong></p>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B11.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="layers-of-vessels" class="title-slide slide level1 center">
<h1>Layers of vessels</h1>
<ul>
<li><strong>Intima</strong>
<ul>
<li><strong>Endothelial cell monolayer</strong></li>
<li><strong>Basal membrane</strong></li>
<li><strong>Internal elastic lamina</strong></li>
</ul></li>
<li><strong>Media</strong>
<ul>
<li><strong>Smooth muscle cells and ECM</strong></li>
<li><strong>Loose connective tissue, nerve fibers, and smaller vessels of the adventitia</strong></li>
<li><strong>External elastic lamina</strong></li>
</ul></li>
<li><strong>Adventitia</strong>
<ul>
<li><strong>Vasa vasorum</strong></li>
</ul></li>
</ul>
</section>

<section id="arteries" class="title-slide slide level1 center">
<h1>Arteries</h1>
<ul>
<li><strong>Large elastic arteries</strong>
<ul>
<li><strong>Aorta, arch vessels, iliac and pulmonary arteries</strong></li>
<li><strong>Elastic fibers alternate with smooth muscle cells throughout the media</strong></li>
<li><strong>Expands during systole, recoils during diastole</strong></li>
<li><strong>Older age, the elasticity is lost</strong>
<ul>
<li><strong>transmit high arterial pressures to distal organs</strong></li>
<li><strong>dilated and tortuous (ectatic) prone to rupture</strong></li>
</ul></li>
</ul></li>
<li><strong>Medium-sized muscular arteries</strong>
<ul>
<li><strong>Coronary and renal arteries</strong></li>
<li><strong>Elastin limited to the internal and external elastic lamina</strong></li>
<li><strong>Media is composed primarily of smooth muscle cells</strong>
<ul>
<li><strong>Circularly or spirally arranged around the lumen</strong></li>
</ul></li>
<li><strong>Regional blood flow is regulated</strong>
<ul>
<li><strong>vasoconstriction vasodilation</strong></li>
<li><strong>Autonomic nervous system, local metabolic factors, acidosis</strong></li>
</ul></li>
</ul></li>
</ul>
<p><strong>Small arteries (&lt;2mm)</strong></p>
<p><strong>Arterioles (20-100 µm)</strong></p>
<p><strong>Connective tissue of organs</strong></p>
<p><strong>Media mostly composed of smooth muscle</strong></p>
<p><strong>Arterioles regulate blood flow resistance</strong></p>
<p><strong>Flow becomes steady rather than pulsatile</strong></p>
</section>

<section id="capillaries" class="title-slide slide level1 center">
<h1>Capillaries</h1>
<p><strong>7-8µm, diameter of RBC</strong></p>
<p><strong>Lined by endothelial cells</strong></p>
<p><strong>Smooth muscle cell-like cells → pericytes</strong></p>
<p><strong>Rapid exchange of diffusible substances between blood and tissue</strong></p>
<p><strong>Diffusion of oxygen and nutrients is not efficient beyond 100 µm</strong></p>
<p><strong>Metabolically active tissues (heart) have the highest capillary density</strong></p>
</section>

<section id="veins" class="title-slide slide level1 center">
<h1>Veins</h1>
<ul>
<li><p><strong>Postcapillary venules</strong></p>
<ul>
<li><strong>Edema</strong></li>
<li><strong>Leukocyte migration</strong></li>
</ul></li>
<li><p><strong>Collecting venules</strong></p></li>
<li><p><strong>Larger veins</strong></p></li>
<li><p><strong>Compared to arteries</strong></p>
<ul>
<li><strong>Veins larger diameters, larger lumina, and thinner walls, less distinct layers</strong></li>
</ul></li>
<li><p><strong>Prone to dilation, external compression, and penetration by tumors or inflammatory processes</strong></p></li>
<li><p><strong>Veins have 2/3 of blood</strong></p>
<ul>
<li><strong>Valves work against gravity</strong></li>
</ul></li>
</ul>
</section>

<section id="lymphatics" class="title-slide slide level1 center">
<h1>Lymphatics</h1>
<p><strong>Thin-walled, endothelium-lined channels</strong></p>
<p><strong>Excess fluid</strong></p>
<p><strong>Proteins</strong></p>
<p><strong>Mononuclear cells</strong></p>
<p><strong>Tumors and infections</strong></p>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B12.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="endothelium" class="title-slide slide level1 center">
<h1>Endothelium</h1>
<ul>
<li><p><strong>Continuous sheet of cells</strong></p></li>
<li><p><strong>Nonthrombogenic blood-tissue interface</strong></p></li>
<li><p><strong>Modulate inflammation</strong></p></li>
<li><p><strong>Affect the growth of other cell types, smooth muscle cells</strong></p></li>
<li><p><strong>Vasoreactivity</strong></p>
<ul>
<li><strong>Relaxation → Nitric oxide</strong></li>
<li><strong>Contracting factors → Endothelin</strong></li>
</ul></li>
<li><p><strong>Interendothelial junctions</strong></p>
<ul>
<li><strong>Open under hemodynamic stress (high blood pressure)</strong></li>
<li><strong>Vasoactive agents (histamine)</strong></li>
</ul></li>
<li><p><strong>Vacuolar transcytosis</strong></p></li>
<li><p><strong>Passage of leukocytes during inflammation</strong></p></li>
<li><p><strong>Fenestrations (holes) in liver and kidney endothelium for filtration</strong></p></li>
<li><p><strong>Central nervous system impermeable blood–brain barrier</strong></p></li>
<li><p><strong>Nonthrombogenic property</strong></p>
<ul>
<li><strong>Laminar flow</strong></li>
<li><strong>Vascular endothelial growth factor</strong></li>
<li><strong>Firm adhesion to basement membrane</strong></li>
</ul></li>
</ul>
</section>

<section id="endothelial-activation" class="title-slide slide level1 center">
<h1>Endothelial activation</h1>
<p><strong>Bacterial products</strong></p>
<p><strong>Inflammatory cytokines</strong></p>
<p><strong>Hemodynamic stresses</strong></p>
<p><strong>Lipid products (atherosclerosis)</strong></p>
<p><strong>Advanced glycolysis products (diabetes)</strong></p>
<p><strong>Viruses</strong></p>
<p><strong>Complement</strong></p>
<p><strong>Metabolic insults (hypoxia)</strong></p>
</section>

<section id="activated-endothelial-cells" class="title-slide slide level1 center">
<h1>Activated endothelial cells</h1>
<ul>
<li><strong>Shape changes</strong></li>
<li><strong>Express adhesion molecules</strong></li>
<li><strong>Produce cytokines, chemokines, growth factors, pro- and anticoagulant factors</strong></li>
<li><strong>Rapid (within minutes)</strong>
<ul>
<li><strong>Reversible, and independent of new protein synthesis</strong></li>
<li><strong>Endothelial contraction by histamines</strong></li>
</ul></li>
<li><strong>Days</strong>
<ul>
<li><strong>Alterations in gene and protein expression</strong></li>
</ul></li>
</ul>
</section>

<section id="endothelial-dysfunction" class="title-slide slide level1 center">
<h1>Endothelial dysfunction</h1>
<p><strong>Endothelium-dependent vasodilation</strong></p>
<p><strong>Hypercoagulable states</strong></p>
<p><strong>Increased oxygen free radical production</strong></p>
<p><strong>Initiate thrombosis</strong></p>
<p><strong>Promote atherosclerosis</strong></p>
<p><strong>Formation of the vascular lesions of hypertension and diabetes</strong></p>
</section>

<section id="vascular-smooth-muscle-cells" class="title-slide slide level1 center">
<h1>Vascular Smooth Muscle Cells</h1>
<p><strong>Normal vascular repair</strong></p>
<p><strong>Atherosclerosis</strong></p>
<p><strong>Proliferate</strong></p>
<p><strong>Upregulate ECM collagen, elastin, and proteoglycan</strong></p>
<p><strong>Form growth factors and cytokines</strong></p>
<p><strong>Mediate vasoconstriction or vasodilation</strong></p>
<ul>
<li><strong>Pro-growth</strong>
<ul>
<li><strong>Platelet-derived growth factor (PDGF)</strong></li>
<li><strong>Endothelin</strong></li>
<li><strong>Thrombin</strong></li>
<li><strong>Fibroblast growth factors</strong></li>
<li><strong>Inflammatory mediators</strong>
<ul>
<li><strong>Interferon-γ (IFN-γ)</strong></li>
<li><strong>Interleukin-1 (IL-1)</strong></li>
</ul></li>
</ul></li>
<li><strong>Quiescent state</strong>
<ul>
<li><strong>Heparan sulfate</strong></li>
<li><strong>NO</strong></li>
<li><strong>Transforming growth factor-α (TGF-α)</strong></li>
</ul></li>
</ul>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B13.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="non-atherosclerotic-vascular-diseases" class="title-slide slide level1 center">
<h1>NON-ATHEROSCLEROTIC VASCULAR DISEASES</h1>

</section>

<section id="congenital-anomalies" class="title-slide slide level1 center">
<h1>CONGENITAL ANOMALIES</h1>

</section>

<section id="berry-aneurysms" class="title-slide slide level1 center">
<h1>Berry aneurysms</h1>
<p><strong>Thin-walled arterial outpouchings in cerebral vessels</strong></p>
<p><strong>Branch points around the circle of Willis</strong></p>
<p><strong>Arterial media is congenitally attenuated</strong></p>
<p><strong>Spontaneously rupture</strong></p>
<p><strong>Fatal intracerebral hemorrhage</strong></p>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B14.png" class="r-stretch"></section>

<section id="arteriovenous-fistulas" class="title-slide slide level1 center">
<h1>Arteriovenous fistulas</h1>
<ul>
<li><strong>Abnormal connections between arteries and veins</strong></li>
<li><strong>No capillary bed</strong></li>
<li><strong>Developmental defects</strong></li>
<li><strong>Rupture of arterial aneurysms into adjacent veins</strong>
<ul>
<li><strong>Penetrating injuries</strong></li>
<li><strong>Inflammatory necrosis of adjacent vessels</strong></li>
</ul></li>
<li><strong>Surgically → hemodialysis</strong></li>
<li><strong>Extensive → cause high-output cardiac failure by shunting</strong></li>
</ul>
</section>

<section id="fibromuscular-dysplasia" class="title-slide slide level1 center">
<h1>Fibromuscular dysplasia</h1>
<ul>
<li><strong>Focal irregular thickening of the walls of medium-sized and large muscular arteries</strong></li>
<li><strong>Medial and intimal hyperplasia and fibrosis</strong></li>
<li><strong>Any age, frequently in young women</strong></li>
<li><strong>Luminal stenosis</strong></li>
<li><strong>Abnormal vessel spasm, reduces vascular flow</strong>
<ul>
<li><strong>Renovascular hypertension</strong></li>
</ul></li>
<li><strong>Between focal segments → vascular outpouchings → rupture</strong></li>
</ul>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B15.png" class="r-stretch"></section>

<section id="disorders-of-blood-vessel-hyperreactivity" class="title-slide slide level1 center">
<h1>DISORDERS OF BLOOD VESSEL HYPERREACTIVITY</h1>

</section>

<section id="raynaud-phenomenon" class="title-slide slide level1 center">
<h1>Raynaud phenomenon</h1>
<ul>
<li><strong>Exaggerated vasoconstriction of arteries and arterioles</strong></li>
<li><strong>In the extremities, fingers and toes</strong></li>
<li><strong>Nose, earlobes, or lips</strong></li>
<li><strong>Paroxysmal pallor or cyanosis</strong>
<ul>
<li><strong>“red-white-and-blue” color changes from most proximal to most distal</strong></li>
<li><strong>Proximal vasodilation, central vasoconstriction, and more distal cyanosis</strong></li>
</ul></li>
</ul>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B16.png" class="r-stretch"></section>

<section id="primary-raynaud-phenomenon" class="title-slide slide level1 center">
<h1>Primary Raynaud phenomenon</h1>
<ul>
<li><strong>Exaggerated central and local vasomotor responses to cold or emotion</strong></li>
<li><strong>3-5% of the general population, young women</strong></li>
<li><strong>Structural changes in the arterial walls are absent</strong></li>
<li><strong>In the late course intimal thickening may appear</strong></li>
<li><strong>The course usually is benign</strong></li>
<li><strong>In chronic cases</strong>
<ul>
<li><strong>Atrophy of the skin, subcutaneous tissues, and muscles</strong></li>
<li><strong>Ulceration and ischemic gangrene are rare</strong></li>
</ul></li>
</ul>
</section>

<section id="secondary-raynaud-phenomenon" class="title-slide slide level1 center">
<h1>Secondary Raynaud phenomenon</h1>
<ul>
<li><strong>Vascular insufficiency due to arterial disease</strong>
<ul>
<li><strong>Systemic lupus erythematosus</strong></li>
<li><strong>Scleroderma</strong></li>
<li><strong>Buerger disease</strong></li>
<li><strong>Atherosclerosis</strong></li>
</ul></li>
</ul>
</section>

<section id="myocardial-vessel-vasospasm" class="title-slide slide level1 center">
<h1>Myocardial Vessel Vasospasm</h1>
<ul>
<li><strong>Excessive constriction cause ischemia</strong></li>
<li><strong>Persistent vasospasm lead to tissue infarction</strong></li>
<li><strong>Endogenous</strong>
<ul>
<li><strong>Epinephrine released by pheochromocytomas</strong></li>
</ul></li>
<li><strong>Exogenous</strong>
<ul>
<li><strong>Cocaine or phenylephrine</strong></li>
</ul></li>
<li><strong>Elevated thyroid hormone increase the sensitivity of vessels to circulating catecholamines</strong></li>
<li><strong>Autoantibodies and T cells in scleroderma cause vascular instability and vasospasm</strong></li>
<li><strong>Extreme psychological stress</strong></li>
</ul>
<p><strong>Vasospasm of cardiac arterial or arteriolar beds (cardiac Raynaud) 20-30 minutes → myocardial infarction</strong></p>
<p><strong>Elevated levels of catechols increase heart rate and myocardial contractility → increase ischemia caused by the vasospasm</strong></p>
<p><strong>Sudden cardiac death (fatal arrhythmia)</strong></p>
<p><strong>Ischemic dilated cardiomyopathy</strong></p>
</section>

<section id="veins-and-lymphatics" class="title-slide slide level1 center">
<h1>VEINS AND LYMPHATICS</h1>

</section>

<section id="varicose-veins-of-the-extremities" class="title-slide slide level1 center">
<h1>Varicose Veins of the Extremities</h1>
<p><strong>Abnormally dilated tortuous veins</strong></p>
<p><strong>Chronically increased intraluminal pressures</strong></p>
<p><strong>Weakened vessel wall support</strong></p>
<p><strong>Superficial veins of the upper and lower leg</strong></p>
<p><strong>20% of men and a third of women develop lower extremity varicose veins</strong></p>
<p><strong>Obesity, compression of the inferior vena cava during pregnancy</strong></p>
<p><strong>Familial tendency</strong></p>
<ul>
<li><strong>Venous valves incompetent</strong></li>
<li><strong>Lower extremity stasis, congestion, edema, pain, and thrombosis</strong></li>
<li><strong>Persistent edema in the extremity</strong></li>
<li><strong>Secondary ischemic skin changes</strong>
<ul>
<li><strong>Stasis dermatitis</strong></li>
<li><strong>Chronic varicose ulcers</strong>
<ul>
<li><strong>Poor wound healing, infections</strong></li>
</ul></li>
</ul></li>
<li><strong>Embolism from these superficial veins is very rare</strong></li>
</ul>
</section>

<section id="congestion-in-portal-vein" class="title-slide slide level1 center">
<h1>Congestion in Portal Vein</h1>
<ul>
<li><strong>Esophageal varices</strong>
<ul>
<li><strong>Liver cirrhosis</strong></li>
<li><strong>Portal vein obstruction</strong></li>
<li><strong>Hepatic vein thrombosis</strong></li>
</ul></li>
<li><strong>Rectum</strong>
<ul>
<li><strong>Hemorrhoids</strong></li>
</ul></li>
<li><strong>Periumbilical veins</strong>
<ul>
<li><strong>Caput medusae</strong></li>
</ul></li>
</ul>
</section>

<section id="thrombophlebitis-and-phlebothrombosis" class="title-slide slide level1 center">
<h1>Thrombophlebitis and Phlebothrombosis</h1>
<p><strong>Thrombosis and inflammation</strong></p>
<p><strong>Deep leg veins</strong></p>
<p><strong>Periprostatic venous plexus in males</strong></p>
<p><strong>Pelvic venous plexus in females</strong></p>
<p><strong>Large veins in the skull and the dural sinuses</strong></p>
<p><strong>Peritoneal infections</strong></p>
<p><strong>Hypercoagulability (polycythemia vera)</strong></p>
</section>

<section id="deep-venous-thrombosis-of-the-legs" class="title-slide slide level1 center">
<h1>Deep venous thrombosis of the legs</h1>
<ul>
<li><strong>Prolonged immobilization</strong>
<ul>
<li><strong>Extended bed rest</strong></li>
<li><strong>Long plane or automobile trips</strong></li>
<li><strong>Postoperative</strong></li>
</ul></li>
<li><strong>Congestive heart failure</strong></li>
<li><strong>Pregnancy</strong></li>
<li><strong>Oral contraceptive use</strong></li>
<li><strong>Obesity</strong></li>
<li><strong>Inherited defects in coagulation factors</strong></li>
<li><strong>Procoagulant factors from malignant tumors</strong>
<ul>
<li><strong>Migratory thrombophlebitis, Trousseau syndrome</strong></li>
</ul></li>
<li><strong>Local manifestations</strong>
<ul>
<li><strong>Distal edema</strong></li>
<li><strong>Cyanosis</strong></li>
<li><strong>Superficial vein dilation</strong></li>
<li><strong>Heat</strong></li>
<li><strong>Tenderness</strong></li>
<li><strong>Redness</strong></li>
<li><strong>Swelling</strong></li>
<li><strong>Pain</strong></li>
</ul></li>
<li><strong>Homan sign</strong>
<ul>
<li><strong>Pain squeezing the calf muscles, forced dorsiflexion of the foot</strong></li>
</ul></li>
<li><strong>Pulmonary embolism</strong></li>
</ul>
</section>

<section id="superior-vena-cava-syndromes" class="title-slide slide level1 center">
<h1>Superior Vena Cava Syndromes</h1>
<p><strong>Neoplasms that compress or invade the superior vena cava</strong></p>
<p><strong>Bronchogenic carcinoma</strong></p>
<p><strong>Mediastinal lymphoma</strong></p>
<p><strong>Marked dilation of the veins of the head, neck, and arms</strong></p>
<p><strong>Cyanosis</strong></p>
<p><strong>Pulmonary vessels compressed → Respiratory distress</strong></p>
</section>

<section id="inferior-vena-cava-syndrome" class="title-slide slide level1 center">
<h1>Inferior vena cava syndrome</h1>
<p><strong>Neoplasms that compress or invade the inferior vena cava</strong></p>
<p><strong>Thrombus from the hepatic, renal, or lower extremity veins</strong></p>
<p><strong>Hepatocellular carcinoma and renal cell carcinoma grow within veins</strong></p>
<p><strong>Marked lower extremity edema</strong></p>
<p><strong>Distention of the superficial collateral veins of the lower abdomen</strong></p>
<p><strong>Proteinuria</strong></p>
</section>

<section id="lymphangitis" class="title-slide slide level1 center">
<h1>Lymphangitis</h1>
<p><strong>Acute inflammatory process by bacterial seeding</strong></p>
<p><strong>Red, painful subcutaneous streaks</strong></p>
<p><strong>Tender enlargement of draining lymph nodes (acute lymphadenitis)</strong></p>
<p><strong>Bacteremia or sepsis</strong></p>
</section>

<section id="lymphedema" class="title-slide slide level1 center">
<h1>Lymphedema</h1>
<ul>
<li><strong>Primary lymphedema</strong>
<ul>
<li><strong>Isolated congenital defect (simple congenital lymphedema)</strong></li>
<li><strong>Familial Milroy disease (heredofamilial congenital lymphedema)</strong>
<ul>
<li><strong>Agenesis or hypoplasia of lymphatics</strong></li>
</ul></li>
</ul></li>
<li><strong>Secondary or obstructive lymphedema</strong>
<ul>
<li><strong>Tumors involving either the lymphatic channels or the regional lymph nodes</strong></li>
<li><strong>Surgical procedures</strong>
<ul>
<li><strong>Axillary lymph nodes in radical mastectomy</strong></li>
</ul></li>
<li><strong>Postradiation fibrosis</strong></li>
<li><strong>Filariasis</strong></li>
<li><strong>Postinflammatory thrombosis and scarring</strong></li>
</ul></li>
<li><strong>Edema</strong></li>
<li><strong>Chronic edema</strong>
<ul>
<li><strong>Deposition of ECM and fibrosis</strong></li>
<li><strong>Brawny induration or a peau d’orange appearance of skin</strong></li>
<li><strong>Inadequate tissue perfusion</strong></li>
<li><strong>Skin ulceration</strong></li>
<li><strong>Rupture of dilated lymphatics</strong></li>
<li><strong>Milky accumulations of lymph in various spaces</strong>
<ul>
<li><strong>Chylous ascites (abdomen), chylothorax, and chylopericardium</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="tumors-of-vessels" class="title-slide slide level1 center">
<h1>TUMORS OF VESSELS</h1>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B17.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="vascular-tumors" class="title-slide slide level1 center">
<h1>Vascular Tumors</h1>
<ul>
<li><strong>Primary tumors of large vessels</strong>
<ul>
<li><strong>Extremely rare and are mostly sarcomas</strong></li>
</ul></li>
<li><strong>Benign tumors</strong>
<ul>
<li><strong>Obvious vascular channels filled with blood cells or lymph</strong></li>
<li><strong>Lined by a monolayer of normal-appearing endothelial cells</strong></li>
</ul></li>
<li><strong>Malignant tumors</strong>
<ul>
<li><strong>More cellular</strong></li>
<li><strong>Cytologic atypia</strong></li>
<li><strong>Proliferative</strong></li>
<li><strong>No well-organized vessels</strong></li>
<li><strong>Immunohistochemical detection of endothelial cell–specific markers</strong>
<ul>
<li><strong>CD31, von Willebrand factor</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="vascular-ectasias" class="title-slide slide level1 center">
<h1>Vascular Ectasias</h1>
<ul>
<li><strong>Dilatation of vessels</strong>
<ul>
<li><strong>Congenital or acquired</strong></li>
<li><strong>Not true neoplasms</strong></li>
</ul></li>
<li><strong>Nevus flammeus (a “birthmark”)</strong></li>
<li><strong>Port wine stain in Sturge-Weber syndrome</strong></li>
<li><strong>Spider telangiectasias in pregnancy, cirrhosis</strong></li>
<li><strong>Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)</strong></li>
</ul>
</section>

<section id="capillary-hemangiomas" class="title-slide slide level1 center">
<h1>Capillary hemangiomas</h1>
<p><strong>Most common type</strong></p>
<p><strong>Skin</strong></p>
<p><strong>Subcutaneous tissues</strong></p>
<p><strong>Mucous membranes of the oral cavities and lips</strong></p>
<p><strong>Liver, spleen, and kidneys</strong></p>
<p><strong>Thin-walled capillaries with scant stroma</strong></p>
<p><img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B18.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B19.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="juvenile-hemangiomas-strawberry-hemangiomas" class="title-slide slide level1 center">
<h1>Juvenile hemangiomasStrawberry hemangiomas</h1>
<p><strong>Newborn skin</strong></p>
<p><strong>Common (1 in 200 births)</strong></p>
<p><strong>Can be multiple</strong></p>
<p><strong>Grow rapidly for a few months but then fade by the age of 1 to 3 years, with complete regression by age 7</strong></p>
</section>

<section id="pyogenic-granulomas" class="title-slide slide level1 center">
<h1>Pyogenic granulomas</h1>
<p><strong>Capillary hemangiomas</strong></p>
<p><strong>Rapidly growing red pedunculated lesions on the skin, gingival, or oral mucosa</strong></p>
<p><strong>Resemble exuberant granulation tissue</strong></p>
<p><strong>Bleed easily and are often ulcerated</strong></p>
<p><strong>Develop after trauma, reaching a size of 1 to 2 cm within a few weeks</strong></p>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B110.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="cavernous-hemangiomas" class="title-slide slide level1 center">
<h1>Cavernous hemangiomas</h1>
<p><strong>Large, dilated vascular channels</strong></p>
<p><strong>More infiltrative, frequently involve deep structures</strong></p>
<p><strong>Do not spontaneously regress</strong></p>
<p><strong>Sharply defined, unencapsulated</strong></p>
<p><strong>Large, cavernous blood-filled vascular spaces, separated by connective tissue stroma</strong></p>
<p><strong>Intravascular thrombosis, dystrophic calcification</strong></p>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B111.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="lymphangiomas" class="title-slide slide level1 center">
<h1>Lymphangiomas</h1>
<ul>
<li><strong>Simple (capillary) lymphangiomas</strong>
<ul>
<li><strong>Head, neck, and axillary subcutaneous tissues</strong></li>
</ul></li>
<li><strong>Cavernous lymphangiomas (cystic hygromas)</strong>
<ul>
<li><strong>Neck or axilla of children, rarely in the retroperitoneum</strong></li>
<li><strong>Can be large (up to 15 cm)</strong></li>
<li><strong>Common in Turner syndrome</strong></li>
<li><strong>Massively dilated lymphatic spaces lined by endothelial cells</strong></li>
<li><strong>Separated by intervening connective tissue stroma containing lymphoid aggregates</strong></li>
<li><strong>Tumor margins are indistinct and unencapsulated, definitive resection difficult</strong></li>
</ul></li>
</ul>
</section>

<section id="glomus-tumors-glomangiomas" class="title-slide slide level1 center">
<h1>Glomus Tumors (Glomangiomas)</h1>
<p><strong>Benign, painful tumors</strong></p>
<p><strong>Specialized smooth muscle cells of glomus bodies</strong></p>
<p><strong>Arteriovenous structures involved in thermoregulation</strong></p>
<p><strong>Distal portion of the digits, especially under the fingernails</strong></p>
<p><strong>Excision is curative</strong></p>
</section>

<section id="bacillary-angiomatosis" class="title-slide slide level1 center">
<h1>Bacillary Angiomatosis</h1>
<p><strong>Vascular proliferation in immunocompromised hosts (AIDS)</strong></p>
<p><strong>Opportunistic gram-negative bacilli of the Bartonella family</strong></p>
<p><strong>Skin, bone, brain, and other organs</strong></p>
<p><strong>Skin lesions are red papules and nodules, or rounded subcutaneous masses</strong></p>
<p><strong>Proliferation of capillaries lined by prominent epithelioid endothelial cells</strong></p>
<p><strong>Nuclear atypia and mitoses</strong></p>
<p><strong>The bacteria induce host tissues to produce HIF-1α, VEGF production and vascular proliferation</strong></p>
<p><strong>Cured by antibiotic treatment</strong></p>
<p><img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B112.png"></p>
<p><strong>Bacillary angiomatosis.</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B113.png"></p>
<p><strong>Bacillary angiomatosis.</strong></p>
<p><strong>B: Histologic features are those of acute inflammation and capillary proliferation. Inset, Modified silver (Warthin-Starry) stain demonstrates clusters of tangled bacilli (black)</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="kaposi-sarcoma" class="title-slide slide level1 center">
<h1>Kaposi Sarcoma</h1>
<ul>
<li><strong>HHV-8</strong></li>
<li><strong>Classical form in elderly</strong></li>
<li><strong>AIDS associated</strong></li>
<li><strong>Transplantation associated</strong></li>
<li><strong>KSHV (HHV8) is a γ-herpesvirus</strong>
<ul>
<li><strong>sexually, non sexually transmitted</strong></li>
</ul></li>
<li><strong>Altered T cell immunity</strong></li>
<li><strong>Lytic and latent infecitons in endothelial cells</strong></li>
<li><strong>Viral G protein induces VEGF production</strong></li>
<li><strong>Viral homologe of cyclin D causes proliferation</strong></li>
<li><strong>Patched, plaque, nodular phases</strong></li>
</ul>
<p><img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B114.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B115.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="hemangioendotheliomas" class="title-slide slide level1 center">
<h1>Hemangioendotheliomas</h1>
<p><strong>Intermediate grade neoplasm</strong></p>
<p><strong>Sometimes resemble epithelial neoplasms morphologically</strong></p>
<p><strong>Excision is curative in a majority of the cases</strong></p>
<p><strong>40% of the tumors recur</strong></p>
<p><strong>20-30% metastasize</strong></p>
<p><strong>15% of patients die of their tumors</strong></p>
</section>

<section id="angiosarcomas" class="title-slide slide level1 center">
<h1>Angiosarcomas</h1>
<p><strong>Malignant endothelial neoplasms</strong></p>
<p><strong>Highly differentiated tumors resembling hemangiomas to wildly anaplastic lesions difficult to distinguish from carcinomas or melanomas</strong></p>
<p><strong>Older adults</strong></p>
<p><strong>No gender bias</strong></p>
<p><strong>Can occur at any site, most often skin, soft tissue, breast, and liver</strong></p>
<ul>
<li><p><strong>Hepatic angiosarcomas</strong></p>
<ul>
<li><strong>Arsenical pesticides</strong></li>
<li><strong>Thorotrast</strong>
<ul>
<li><strong>A radioactive contrast agent formerly used for radiologic imaging)</strong></li>
</ul></li>
<li><strong>Polyvinyl chloride</strong></li>
</ul></li>
<li><p><strong>Arise in patients with lymphedema</strong></p>
<ul>
<li><strong>Axillary lymph node resection for breast cancer</strong></li>
<li><strong>Lymphangiosarcoma</strong></li>
</ul></li>
<li><p><strong>Can be induced by radiation</strong></p></li>
<li><p><strong>Long-term (years) foreign bodies (catheters)</strong></p></li>
<li><p><strong>Skin</strong></p>
<ul>
<li><strong>Begin as small, sharply demarcated, asymptomatic red nodules</strong></li>
<li><strong>Advanced lesions</strong>
<ul>
<li><strong>Large, fleshy red-tan to gray-white masses</strong></li>
<li><strong>Necrosis and hemorrhage</strong></li>
</ul></li>
</ul></li>
<li><p><strong>Aggressive tumors that invade locally and metastasize</strong></p></li>
<li><p><strong>5-year survival rates 30%</strong></p></li>
</ul>
<p><img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B116.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B117.png"></p>
<p><img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B118.png"></p>
<p><strong>Moderately differentiated angiosarcoma with dense clumps of atypical cells lining distinct vascular lumina</strong></p>
<p><strong>Immunohistochemical staining of angiosarcoma for the endothelial cell marker CD31</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="vascular-intervention" class="title-slide slide level1 center">
<h1>Vascular Intervention</h1>
<p><strong>Thrombosis, intimal thickening and atherosclerosis is seen after stent or grafts</strong></p>

<img data-src="img%5CNon-Atherosclerotic-Vascular-Diseasespptx-kopyas%C4%B119.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
<div class="footer footer-default">

</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="non-atherosclerotic-vascular-diseases-_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'smaller': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
      function tippyHover(el, contentFn) {
        const config = {
          allowHTML: true,
          content: contentFn,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        };
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          return note.innerHTML;
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>